WAC 246-101-101

WAC 246-101-101. Notifiable conditions — Health care providers and health care facilities

Last amended: 2023Year: 2026Length: 2,754 wordsOfficial source
(1) For the purposes of this section: (a) "Local health jurisdiction" means where the patient resides, or, in the event the patient's residence cannot be determined, the local health jurisdiction in which the patient received treatment. (b) "Unexplained critical illness or death" means a severe illness or death with infectious hallmarks, but no known etiology, in a previously healthy person one to forty-nine years of age excluding those with chronic medical conditions such as malignancy, diabetes, AIDS, or cirrhosis. (2) The conditions identified in Table HC-1 are notifiable to public health authorities under this table and this chapter. Table HC-1 (Conditions Notifiable by Health Care Providers and Health Care Facilities) Notifiable Condition (Agent) Laboratory Confirmation Required Before Submitting Case Report Time Frame for Notification from Identification of a Case Who Must Be Notified Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) Acquired immunodeficiency syndrome (AIDS) Within 3 business days DOH (for facilities) and LHJ (for providers) Both Amebic meningitis Immediately LHJ Both Anaplasmosis Within 3 business days LHJ Both Anthrax ( Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus ) Yes Immediately LHJ Both Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infection See also "Yellow fever" Within 3 business days LHJ Both Asthma, occupational Within 30 days Washington state department of labor and industries (L&I) Both Babesiosis Within 3 business days LHJ Both Baylisascariasis Within 24 hours LHJ Both Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) Within 30 days DOH Facilities Birth defects - Autism spectrum disorders Within 30 days DOH Both Birth defects - Cerebral palsy Within 30 days DOH Both Birth defects - Down syndrome Within 30 days DOH Facilities Birth defects - Alcohol related birth defects Within 30 days DOH Both Birth defects - Hypospadias Within 30 days DOH Facilities Birth defects - Limb reductions Within 30 days DOH Facilities Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) Within 30 days DOH Facilities Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) Within 30 days DOH Facilities Blood lead level RST results ( See WAC 246-101-200 ) Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Botulism, foodborne, infant, and wound Immediately LHJ Both Brucellosis Within 24 hours LHJ Both Campylobacteriosis Within 3 business days LHJ Both Cancer ( See chapter 246-102 WAC ) Candida auris infection or colonization Within 24 hours LHJ Both Carbapenem-resistant Enterobacteriaceae infections limited to: Klebsiella species E. coli Enterobacter species Yes Within 3 business days LHJ Both Chagas disease Within 3 business days LHJ Both Chancroid Within 3 business days LHJ Both Chlamydia trachomatis infection Yes Within 3 business days LHJ Both Cholera ( Vibrio cholerae O1 or O139) Yes Immediately LHJ Both Coccidioidomycosis Within 3 business days LHJ Both Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) Yes Immediately LHJ Both Coronavirus infection (severe communicable) Novel coronavirus (COVID-19) RST results ( See WAC 246-101-200 ) Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C . neoformans ) Yes Within 3 business days LHJ Both Cryptosporidiosis Within 3 business days LHJ Both Cyclosporiasis Within 3 business days LHJ Both Cysticercosis Within 3 business days LHJ Both Diphtheria Immediately LHJ Both Domoic acid poisoning Immediately LHJ Both E. coli ( See "Shiga toxin-producing E. coli" ) Echinococcosis Within 3 business days LHJ Both Ehrlichiosis Within 3 business days LHJ Both Giardiasis Within 3 business days LHJ Both Glanders ( Burkholderia mallei ) Yes Immediately LHJ Both Gonorrhea Within 3 business days LHJ Both Granuloma inguinale Within 3 business days LHJ Both Gunshot wounds (nonfatal) Within 30 days DOH Facilities Haemophilus influenzae (invasive disease, children under 5 years of age) Yes Immediately LHJ Both Hantaviral infection Within 24 hours LHJ Both Hepatitis A (acute infection) Yes Within 24 hours LHJ Both Hepatitis B (acute infection) Yes Within 24 hours LHJ Both Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) Yes Within 3 business days LHJ Both Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases Yes Within 3 business days LHJ Both Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases Yes Within 3 business days LHJ Both Hepatitis C (acute infection) Yes Within 24 hours LHJ Both Hepatitis C (acute infection) RST results ( See WAC 246-101-200 ) Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Hepatitis C (chronic infection) Yes Within 3 business days LHJ Both Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases Yes Within 24 hours LHJ Both Hepatitis C (chronic infection) RST results ( See WAC 246-101-200 ) Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Hepatitis D (acute and chronic infection) Yes Within 24 hours LHJ Both Hepatitis E (acute infection) Yes Within 24 hours LHJ Both Herpes simplex, neonatal and genital (initial infection only) Within 3 business days LHJ Providers Histoplasmosis Within 3 business days LHJ Both Human immunodeficiency virus (HIV) infection Within 3 business days LHJ Both Human immunodeficiency virus (HIV) infection RST results ( See WAC 246-101-200 ) Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Human prion disease Within 3 business days LHJ Both Hypersensitivity pneumonitis, occupational Within 30 days L&I Both Influenza, novel or unsubtypable strain Immediately LHJ Both Influenza-associated death (laboratory confirmed) Yes Within 3 business days LHJ Both Legionellosis Within 24 hours LHJ Both Leptospirosis Within 24 hours LHJ Both Listeriosis Within 24 hours LHJ Both Lyme disease Within 3 business days LHJ Both Lymphogranuloma venereum Within 3 business days LHJ Both Malaria Within 3 business days LHJ Both Measles (rubeola) - Acute disease only Immediately LHJ Both Melioidosis ( Burkholderia pseudomallei ) Yes Immediately LHJ Both Meningococcal disease, invasive Immediately LHJ Both Monkeypox Immediately LHJ Both Mumps, acute disease only Within 24 hours LHJ Both Outbreaks and suspected outbreaks Immediately LHJ Both Paralytic shellfish poisoning Immediately LHJ Both Pertussis Within 24 hours LHJ Both Pesticide poisoning (hospitalized, fatal, or cluster) Immediately DOH Both Pesticide poisoning (all other) Within 3 business days DOH Both Plague Immediately LHJ Both Poliomyelitis Immediately LHJ Both Pregnancy in patient with hepatitis B virus See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" Psittacosis Within 24 hours LHJ Both Q fever Within 24 hours LHJ Both Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) Yes for animal cases Immediately LHJ Both Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) Immediately LHJ Both Relapsing fever (borreliosis) Within 3 business days LHJ Both Rickettsia infection Within 3 business days LHJ Both Rubella, acute disease only (including congenital rubella syndrome) Immediately LHJ Both Salmonellosis Within 24 hours LHJ Both Serious adverse reactions to immunizations Within 3 business days LHJ Both Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections Yes Immediately LHJ Both Shigellosis Within 24 hours LHJ Both Silicosis Within 30 days L&I Both Smallpox Immediately LHJ Both Syphilis Within 3 business days LHJ Both Taeniasis Within 3 business days LHJ Both Tetanus Within 3 business days LHJ Both Tick paralysis Within 3 business days LHJ Both Trichinosis Within 3 business days LHJ Both Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) Within 24 hours LHJ Both Tularemia Immediately LHJ Both Typhus Within 3 business days LHJ Both Vaccinia transmission Immediately LHJ Both Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) Yes Within 24 hours LHJ Both Varicella-associated death Within 3 business days LHJ Both Vibriosis ( Vibrio species not including Vibrio cholerae O1 or O139) See Cholera ( Vibrio cholerae O1 or O139) Yes Within 24 hours LHJ Both Viral hemorrhagic fever Immediately LHJ Both Yellow fever Immediately LHJ Both Yersiniosis Within 24 hours LHJ Both Unexplained critical illness or death Within 24 hours LHJ Both Notifiable Condition (Agent) Laboratory Confirmation Required Before Submitting Case Report Time Frame for Notification from Identification of a Case Who Must Be Notified Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) Acquired immunodeficiency syndrome (AIDS) Within 3 business days DOH (for facilities) and LHJ (for providers) Both Amebic meningitis Immediately LHJ Both Anaplasmosis Within 3 business days LHJ Both Anthrax ( Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus ) Yes Immediately LHJ Both Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infection See also "Yellow fever" Within 3 business days LHJ Both Asthma, occupational Within 30 days Washington state department of labor and industries (L&I) Both Babesiosis Within 3 business days LHJ Both Baylisascariasis Within 24 hours LHJ Both Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) Within 30 days DOH Facilities Birth defects - Autism spectrum disorders Within 30 days DOH Both Birth defects - Cerebral palsy Within 30 days DOH Both Birth defects - Down syndrome Within 30 days DOH Facilities Birth defects - Alcohol related birth defects Within 30 days DOH Both Birth defects - Hypospadias Within 30 days DOH Facilities Birth defects - Limb reductions Within 30 days DOH Facilities Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) Within 30 days DOH Facilities Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) Within 30 days DOH Facilities Blood lead level RST results ( See WAC 246-101-200 ) Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Botulism, foodborne, infant, and wound Immediately LHJ Both Brucellosis Within 24 hours LHJ Both Campylobacteriosis Within 3 business days LHJ Both Cancer ( See chapter 246-102 WAC ) Candida auris infection or colonization Within 24 hours LHJ Both Carbapenem-resistant Enterobacteriaceae infections limited to: Klebsiella species E. coli Enterobacter species Yes Within 3 business days LHJ Both Chagas disease Within 3 business days LHJ Both Chancroid Within 3 business days LHJ Both Chlamydia trachomatis infection Yes Within 3 business days LHJ Both Cholera ( Vibrio cholerae O1 or O139) Yes Immediately LHJ Both Coccidioidomycosis Within 3 business days LHJ Both Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) Yes Immediately LHJ Both Coronavirus infection (severe communicable) Novel coronavirus (COVID-19) RST results ( See WAC 246-101-200 ) Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C . neoformans ) Yes Within 3 business days LHJ Both Cryptosporidiosis Within 3 business days LHJ Both Cyclosporiasis Within 3 business days LHJ Both Cysticercosis Within 3 business days LHJ Both Diphtheria Immediately LHJ Both Domoic acid poisoning Immediately LHJ Both E. coli ( See "Shiga toxin-producing E. coli" ) Echinococcosis Within 3 business days LHJ Both Ehrlichiosis Within 3 business days LHJ Both Giardiasis Within 3 business days LHJ Both Glanders ( Burkholderia mallei ) Yes Immediately LHJ Both Gonorrhea Within 3 business days LHJ Both Granuloma inguinale Within 3 business days LHJ Both Gunshot wounds (nonfatal) Within 30 days DOH Facilities Haemophilus influenzae (invasive disease, children under 5 years of age) Yes Immediately LHJ Both Hantaviral infection Within 24 hours LHJ Both Hepatitis A (acute infection) Yes Within 24 hours LHJ Both Hepatitis B (acute infection) Yes Within 24 hours LHJ Both Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) Yes Within 3 business days LHJ Both Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases Yes Within 3 business days LHJ Both Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases Yes Within 3 business days LHJ Both Hepatitis C (acute infection) Yes Within 24 hours LHJ Both Hepatitis C (acute infection) RST results ( See WAC 246-101-200 ) Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Hepatitis C (chronic infection) Yes Within 3 business days LHJ Both Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases Yes Within 24 hours LHJ Both Hepatitis C (chronic infection) RST results ( See WAC 246-101-200 ) Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Hepatitis D (acute and chronic infection) Yes Within 24 hours LHJ Both Hepatitis E (acute infection) Yes Within 24 hours LHJ Both Herpes simplex, neonatal and genital (initial infection only) Within 3 business days LHJ Providers Histoplasmosis Within 3 business days LHJ Both Human immunodeficiency virus (HIV) infection Within 3 business days LHJ Both Human immunodeficiency virus (HIV) infection RST results ( See WAC 246-101-200 ) Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230 . Human prion disease Within 3 business days LHJ Both Hypersensitivity pneumonitis, occupational Within 30 days L&I Both Influenza, novel or unsubtypable strain Immediately LHJ Both Influenza-associated death (laboratory confirmed) Yes Within 3 business days LHJ Both Legionellosis Within 24 hours LHJ Both Leptospirosis Within 24 hours LHJ Both Listeriosis Within 24 hours LHJ Both Lyme disease Within 3 business days LHJ Both Lymphogranuloma venereum Within 3 business days LHJ Both Malaria Within 3 business days LHJ Both Measles (rubeola) - Acute disease only Immediately LHJ Both Melioidosis ( Burkholderia pseudomallei ) Yes Immediately LHJ Both Meningococcal disease, invasive Immediately LHJ Both Monkeypox Immediately LHJ Both Mumps, acute disease only Within 24 hours LHJ Both Outbreaks and suspected outbreaks Immediately LHJ Both Paralytic shellfish poisoning Immediately LHJ Both Pertussis Within 24 hours LHJ Both Pesticide poisoning (hospitalized, fatal, or cluster) Immediately DOH Both Pesticide poisoning (all other) Within 3 business days DOH Both Plague Immediately LHJ Both Poliomyelitis Immediately LHJ Both Pregnancy in patient with hepatitis B virus See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" Psittacosis Within 24 hours LHJ Both Q fever Within 24 hours LHJ Both Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) Yes for animal cases Immediately LHJ Both Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) Immediately LHJ Both Relapsing fever (borreliosis) Within 3 business days LHJ Both Rickettsia infection Within 3 business days LHJ Both Rubella, acute disease only (including congenital rubella syndrome) Immediately LHJ Both Salmonellosis Within 24 hours LHJ Both Serious adverse reactions to immunizations Within 3 business days LHJ Both Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections Yes Immediately LHJ Both Shigellosis Within 24 hours LHJ Both Silicosis Within 30 days L&I Both Smallpox Immediately LHJ Both Syphilis Within 3 business days LHJ Both Taeniasis Within 3 business days LHJ Both Tetanus Within 3 business days LHJ Both Tick paralysis Within 3 business days LHJ Both Trichinosis Within 3 business days LHJ Both Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) Within 24 hours LHJ Both Tularemia Immediately LHJ Both Typhus Within 3 business days LHJ Both Vaccinia transmission Immediately LHJ Both Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) Yes Within 24 hours LHJ Both Varicella-associated death Within 3 business days LHJ Both Vibriosis ( Vibrio species not including Vibrio cholerae O1 or O139) See Cholera ( Vibrio cholerae O1 or O139) Yes Within 24 hours LHJ Both Viral hemorrhagic fever Immediately LHJ Both Yellow fever Immediately LHJ Both Yersiniosis Within 24 hours LHJ Both Unexplained critical illness or death Within 24 hours LHJ Both
WAC 246-101-101: WAC 246-101-101. Notifiable conditions — Health care providers and health care facilities | Justis AI